The following represents disclosure information provided by faculty of the educational and scientific sessions. The Committee have reviewed all presented disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Discussion
 
Tian Zhang
 
Employment - No Relationships to Disclose
 
Leadership - Archimmune Therapeutics (I); Capio BioSciences (I)
 
Stock and Other Ownership Interests - Archimmune Therapeutics (I); Capio Biosciences (I); Nanorobotics (I)
 
Honoraria - Aptitude Health; Clinical Care Options; Curio Science; MJH Life Sciences; Peerview
 
Consulting or Advisory Role - Aravive; AstraZeneca; AVEO; Bayer; Bristol-Myers Squibb; Eisai; EMD Serono; Exelixis; Gilead Sciences; Janssen; Lilly; Loxo/Lilly; Merck; Novartis; Pfizer; Sanofi/Aventis; Seagen; Xencor
 
Speakers' Bureau - No Relationships to Disclose
 
Research Funding - ALX Oncology (Inst); Astellas Pharma (Inst); Exelixis (Inst); Janssen (Inst); Janux Therapeutics (Inst); Loxo/Lilly (Inst); OncoC4; Pfizer (Inst); Tempus (Inst)
 
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture by c-MET technology (Inst); Prochelators as Targeted Prodrugs for Prostate Cancer (Inst)
 
Expert Testimony - No Relationships to Disclose
 
Travel, Accommodations, Expenses - Bayer
 
Other Relationship - ASCO; Kidney Cancer Association; KidneyCan; Myrovlytis Trust
 
(OPTIONAL) Uncompensated Relationships - No Relationships to Disclose
 
(OPTIONAL) Open Payments Link - No Relationships to Disclose